Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted Therapy for Fibromyalgia
NCT06066853Phase 1Recruiting
- Sponsor
- Spaulding Rehabilitation Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of midomafetamine in fibromyalgia (FM), sponsored by Spaulding Rehabilitation Hospital. Primary endpoint: Brief Pain Inventory at 3 months. Started Sep 2026; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT06066853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06066853.